Ferrexpo (FXPO) Competitors

Zanaga Iron Ore has higher earnings, but lower revenue than Ferrexpo. Ferrexpo is trading at a lower price-to-earnings ratio than Zanaga Iron Ore, indicating that it is currently the more affordable of the two stocks.

Ferrexpo has a consensus price target of GBX 53, indicating a potential upside of 63.08%. Given Ferrexpo's stronger consensus rating and higher possible upside, analysts clearly believe Ferrexpo is more favorable than Zanaga Iron Ore.

2.2% of Zanaga Iron Ore shares are held by institutional investors. Comparatively, 8.8% of Ferrexpo shares are held by institutional investors. 12.9% of Zanaga Iron Ore shares are held by insiders. Comparatively, 28.8% of Ferrexpo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Zanaga Iron Ore has a beta of 1.863, meaning that its share price is 86% more volatile than the broader market. Comparatively, Ferrexpo has a beta of 0.627, meaning that its share price is 37% less volatile than the broader market.

Zanaga Iron Ore has a net margin of 0.00% compared to Ferrexpo's net margin of -8.06%. Ferrexpo's return on equity of -6.33% beat Zanaga Iron Ore's return on equity.

In the previous week, Zanaga Iron Ore had 2 more articles in the media than Ferrexpo. MarketBeat recorded 2 mentions for Zanaga Iron Ore and 0 mentions for Ferrexpo. Zanaga Iron Ore's average media sentiment score of 0.48 beat Ferrexpo's score of 0.00 indicating that Zanaga Iron Ore is being referred to more favorably in the media.

Realm Therapeutics has a net margin of 0.00% compared to Ferrexpo's net margin of -8.06%. Realm Therapeutics' return on equity of 0.00% beat Ferrexpo's return on equity.

In the previous week, Realm Therapeutics' average media sentiment score of 0.00 equaled Ferrexpo'saverage media sentiment score.

Realm Therapeutics has higher earnings, but lower revenue than Ferrexpo. Ferrexpo is trading at a lower price-to-earnings ratio than Realm Therapeutics, indicating that it is currently the more affordable of the two stocks.

Ferrexpo has a consensus target price of GBX 53, indicating a potential upside of 63.08%. Given Ferrexpo's stronger consensus rating and higher probable upside, analysts plainly believe Ferrexpo is more favorable than Realm Therapeutics.

8.8% of Ferrexpo shares are owned by institutional investors. 28.8% of Ferrexpo shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

8.8% of Ferrexpo shares are held by institutional investors. Comparatively, 0.1% of Rockfire Resources shares are held by institutional investors. 28.8% of Ferrexpo shares are held by insiders. Comparatively, 6.0% of Rockfire Resources shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Rockfire Resources has a net margin of 0.00% compared to Ferrexpo's net margin of -8.06%. Ferrexpo's return on equity of -6.33% beat Rockfire Resources' return on equity.

Ferrexpo has a beta of 0.627, indicating that its share price is 37% less volatile than the broader market. Comparatively, Rockfire Resources has a beta of 0.38, indicating that its share price is 62% less volatile than the broader market.

In the previous week, Rockfire Resources had 3 more articles in the media than Ferrexpo. MarketBeat recorded 3 mentions for Rockfire Resources and 0 mentions for Ferrexpo. Ferrexpo's average media sentiment score of 0.00 beat Rockfire Resources' score of 0.00 indicating that Ferrexpo is being referred to more favorably in the media.

Ferrexpo presently has a consensus target price of GBX 53, suggesting a potential upside of 63.08%. Given Ferrexpo's stronger consensus rating and higher probable upside, equities research analysts clearly believe Ferrexpo is more favorable than Rockfire Resources.

Rockfire Resources has lower revenue, but higher earnings than Ferrexpo. Ferrexpo is trading at a lower price-to-earnings ratio than Rockfire Resources, indicating that it is currently the more affordable of the two stocks.

In the previous week, Ironveld had 1 more articles in the media than Ferrexpo. MarketBeat recorded 1 mentions for Ironveld and 0 mentions for Ferrexpo. Ferrexpo's average media sentiment score of 0.00 beat Ironveld's score of -0.54 indicating that Ferrexpo is being referred to more favorably in the news media.

Ironveld has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Comparatively, Ferrexpo has a beta of 0.627, meaning that its share price is 37% less volatile than the broader market.

Ferrexpo has a net margin of -8.06% compared to Ironveld's net margin of -35,975.00%. Ferrexpo's return on equity of -6.33% beat Ironveld's return on equity.

Ferrexpo has a consensus price target of GBX 53, indicating a potential upside of 63.08%. Given Ferrexpo's stronger consensus rating and higher probable upside, analysts plainly believe Ferrexpo is more favorable than Ironveld.

Ironveld has higher earnings, but lower revenue than Ferrexpo. Ironveld is trading at a lower price-to-earnings ratio than Ferrexpo, indicating that it is currently the more affordable of the two stocks.

2.4% of Ironveld shares are held by institutional investors. Comparatively, 8.8% of Ferrexpo shares are held by institutional investors. 25.3% of Ironveld shares are held by company insiders. Comparatively, 28.8% of Ferrexpo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.